CTOs on the Move

Gliknik

www.gliknik.com

 
Gliknik Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.gliknik.com
  • 801 W Baltimore St
    Baltimore, MD USA 21201
  • Phone: 410.685.0662

Executives

Name Title Contact Details

Funding

Gliknik raised $15M on 02/19/2019

Similar Companies

EMD Biosciences

EMD Biosciences is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Locana

Locana is a RNA-targeting gene therapy company

Paragon Biosciences

Paragon Biosciences invests in and launches biopharmaceutical companies to develop novel therapies for severe medical conditions which do not yet have adequate treatments. Our mission is to help people live longer, healthier lives. Paragon advances that mission through its contribution of Bioscience Innovation Capital(TM): For rare and complex diseases, Paragon analyzes the viability of potential therapies, invests in new biopharmaceutical companies to further develop promising treatments, catalyzes the progress of its portfolio companies through early-incubation services, and provides clinical and regulatory guidance by a team with a near-perfect track record of first-cycle novel drug approvals.

Woodcock Washburn

Woodcock Washburn is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Biosciences

Pacific Biosciences is developing an environment in which scientists can seamlessly integrate multiple data types from multiple sources and deploy advanced bioinformatics methods to elucidate the complexity of living systems. Therefore, we are committed